Characteristics of patients with non-severe infections of different SARS-CoV-2 omicron subvariants in China

ObjectiveThe aim of this study was to explore the clinical characteristics of patients infected with different Omicron subvariants presenting non-severe disease, evaluate the safety and efficacy of Azvudine for treatment of COVID-19, in order to broaden understanding of Omicron subvariant infections...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Frontiers in Medicine
المؤلفون الرئيسيون:	Wenfang Yuan, Yongmei Liu, Haoting Zhan, Feng Wei, Qian Zhang, Huixia Gao, Huimin Yan, Tao Huang, Yongzhe Li, Erhei Dai
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Frontiers Media S.A. 2024-12-01
الموضوعات:	omicron subvariant BA.2.76 BA.5.1 clinical features Azvudine nucleic acid negativization
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1511227/full

مواد مشابهة

Mapping the Early Dispersal Patterns of SARS-CoV-2 Omicron BA.4 and BA.5 Subvariants in the Absence of Travel Restrictions and Testing at the Borders in Europe
حسب: Evangelia Georgia Kostaki, وآخرون
منشور في: (2022-12-01)

Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January–March 2022
حسب: Daniela Loconsole, وآخرون
منشور في: (2022-04-01)

Omicron subvariant BA.5 is highly contagious but containable: Successful experience from Macau
حسب: Cong Xu, وآخرون
منشور في: (2023-01-01)

Differences in clinical characteristics and liver injury between patients diagnosed with the Omicron subvariant BA.5.2 and the prototype of SARS-CoV-2: a single center retrospective study
حسب: Jie Li, وآخرون
منشور في: (2023-08-01)

Redistribution and Activation of CD16brightCD56dim NK Cell Subset to Fight against Omicron Subvariant BA.2 after COVID-19 Vaccination
حسب: Huiyun Peng, وآخرون
منشور في: (2023-04-01)

The presence of neutralizing antibodies against omicron subvariants among a vaccinated cohort at one year after the first dose of vaccination in Malaysia
حسب: Eida Nurhadzira Muhammad, وآخرون
منشور في: (2025-06-01)

Evaluating in vivo effectiveness of sotrovimab for the treatment of Omicron subvariant BA.2 versus BA.1: a multicentre, retrospective cohort study
حسب: Carson K. L. Lo, وآخرون
منشور في: (2024-01-01)

Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review
حسب: Shaheen N, وآخرون
منشور في: (2022-10-01)

Development of a panel of three multiplex allele-specific qRT-PCR assays for quick differentiation of recombinant variants and Omicron subvariants of SARS-CoV-2
حسب: Jianguo Li, وآخرون
منشور في: (2022-08-01)

Clinical severity of Delta and 3 different Omicron sublineages in patients hospitalized because of COVID-19 in a Swiss tertiary center
حسب: Erol Orel, وآخرون
منشور في: (2024-11-01)

Transmission characteristics and inactivated vaccine effectiveness against transmission of the SARS-CoV-2 Omicron BA.2 variant in Shenzhen, China
حسب: Xiaofeng He, وآخرون
منشور في: (2024-01-01)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
حسب: Hanzhong Ke, وآخرون
منشور في: (2022-09-01)

Differential immunity induced by Omicron sublineages in naïve and vaccine breakthrough infections
حسب: Noah Brazer, وآخرون
منشور في: (2025-07-01)

Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tractResearch in context
حسب: Bingjie Hu, وآخرون
منشور في: (2024-01-01)

Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
حسب: Jinghao Nicholas Ngiam, وآخرون
منشور في: (2024-12-01)

Research of Epidemiologic Feature and Control of SARS-CoV-2 Omicron Subvariants BA.4 and BA.5
حسب: Yu WU, Jue LIU, Min LIU, Wannian LIANG
منشور في: (2022-10-01)

CLINICAL EVALUATION OF OMICRON SUBVARIANT BA. 2- A HOSPITAL BASED STUDY
حسب: Pratiti Datta, وآخرون
منشور في: (2023-06-01)

Uninvited Guest: Arrival and Dissemination of Omicron Lineage SARS-CoV-2 in St. Petersburg, Russia
حسب: Anna Gladkikh, وآخرون
منشور في: (2022-08-01)

Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
حسب: Srijan Chatterjee, وآخرون
منشور في: (2023-06-01)

Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants
حسب: Chiranjib Chakraborty, وآخرون
منشور في: (2023-03-01)

SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals
حسب: Maarten E. Emmelot, وآخرون
منشور في: (2022-12-01)

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
حسب: Xue-Jun Wang, وآخرون
منشور في: (2022-12-01)

The epidemiology and phylogenetic trends of Omicron subvariants from BA.5 to XBB.1 in Taiwan
حسب: Jih-Jin Tsai, وآخرون
منشور في: (2024-11-01)

Occurrence of the Omicron variant of SARS-CoV-2 in northern Viet Nam in early 2022
حسب: Trang thi Hong Ung, وآخرون
منشور في: (2022-09-01)

Differentiating Cell Entry Potentials of SARS-CoV-2 Omicron Subvariants on Human Lung Epithelium Cells
حسب: Revansiddha H. Katte, وآخرون
منشور في: (2024-03-01)

Genomic profile of SARS-CoV-2 Omicron variant and its correlation with disease severity in Rajasthan
حسب: Ravi P. Sharma, وآخرون
منشور في: (2022-09-01)

Genomic Surveillance of SARS-CoV-2 in Malaysia during the Era of Endemic COVID-19
حسب: Tze Yan Lee, وآخرون
منشور في: (2023-07-01)

Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages
حسب: Bradley K. Ackerson, وآخرون
منشور في: (2024-12-01)

Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD
حسب: Qianqian Li, وآخرون
منشور في: (2022-06-01)

The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: A systematic review
حسب: Aparajita Sarkar, وآخرون
منشور في: (2023-01-01)

The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of Omicron
حسب: Tanner Wiegand, وآخرون
منشور في: (2022-09-01)

Structural Basis for the Enhanced Infectivity and Immune Evasion of Omicron Subvariants
حسب: Yaning Li, وآخرون
منشور في: (2023-06-01)

COVID-19 Bivalent Booster in Pregnancy: Maternal and Neonatal Antibody Response to Omicron BA.5, BQ.1, BF.7 and XBB.1.5 SARS-CoV-2
حسب: Wei-Chun Chen, وآخرون
منشور في: (2023-08-01)

Rapid Identification of SARS-CoV-2 Omicron BA.5 Spike Mutation F486V in Clinical Specimens Using a High-Resolution Melting-Based Assay
حسب: Akira Aoki, وآخرون
منشور في: (2022-10-01)

Structural Insight into the Resistance of the SARS-CoV-2 Omicron BA.4 and BA.5 Variants to Cilgavimab
حسب: Shigeru Fujita, وآخرون
منشور في: (2022-11-01)

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
حسب: Anupriya Aggarwal, وآخرون
منشور في: (2022-10-01)

Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants
حسب: Panke Qu, وآخرون
منشور في: (2023-02-01)

Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa
حسب: Mary-Ann Davies, وآخرون
منشور في: (2023-02-01)

The Epidemiological Features of the SARS-CoV-2 Omicron Subvariant BA.5 and Its Evasion of the Neutralizing Activity of Vaccination and Prior Infection
حسب: Dandan Tian, وآخرون
منشور في: (2022-10-01)

Characteristics and containment of the outbreak caused by the SARS-CoV-2 Omicron variants in Shanghai, China: A retrospective study
حسب: Hongrang Zhou, وآخرون
منشور في: (2022-01-01)